Stage V is a comprehensive evaluation phase within the public procurement of innovation process (PCP&PPI). This evaluation is conducted holistically. On the one hand, it involves gathering the lessons learned throughout the procurement process, with the aim of improving the implementation of the instrument and preventing future errors or issues. On the other hand, it seeks to assess the project’s outcomes, impact and innovation adoption capacity, specifically, the extent to which they meet the project’s initial expectations, the adequacy of such expectations and the suitability of the proposed technologies and solutions. Additionally, the current context will be evaluated, including healthcare system or purchasing organization priorities, barriers and drivers for adoption, as well as market trends or emerging technologies that could enhance the proposed solutions or their implementation. Following this complete and holistic assessment, an analysis will be conducted to estimate the sustainability or GO/NO-GO decision of the project or even the scaling-up at regional or national level. This analysis will include the buyer’s interest and capacity to continue engaging with the innovation and/or available market solutions. It will also include innovation provider’s perspective as the innovation roadmap for achieving a marketable solution. Sustainability may take several forms such as, new agreement or tender agreement, negotiating a continuation of the contract, formalizing a Letter of Intent (LOI), or a joint publications/events participation.